CompletedPhase 4

Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

United States240 participantsStarted 2016-05

Plain-language summary

The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that receive just acupressure point P6 stimulation.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female subjects ages 18 to 45
✓. Subjects with ASA Class I or II
✓. Subjects with elective primary or repeat cesarean delivery
✓. Subjects who receive spinal and/or epidural anesthesia
✓. English and non-English speaking subjects will be included in the study

Exclusion criteria

✕. Female subjects \<18 years of age
✕. Subjects requiring emergent cesarean delivery
✕. Gestational age \< 37 weeks
✕. History of placenta accreta
✕. Multiple gestation pregnancy
✕. ASA status III or higher
✕. Current history of pregnancy induced hypertension, pre-eclampsia, or eclampsia
✕. History of any chronic medication use (other than prenatal vitamins), including inhaler medications

What they're measuring

Number of Patients With Nausea

Timeframe: Throughout the entire surgical procedure

Number of Patients With Vomiting

Timeframe: Throughout the surgical procedure

Trial details

NCT IDNCT02960113

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09

Results submitted2022-08-07

View on ClinicalTrials.gov More Nausea trials